MedTrace Logo

DIAbetes TEam and Cgm in Managing Hospitalised Patients with Diabetes

NCT05803473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2025-02-26

No results posted yet for this study

Summary

This trial investigates the effects of continuous glucose monitoring (CGM) and an in-hospital diabetes team on in-hospital glycemic and clinical outcomes in patients with type 2 diabetes compared to standard glucose point-of-care (POC) testing and an in-hospital diabetes team.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DEVICE

Dexcom G6 Continuous Glucose Monitoring System (Dexcom Inc., San Diego, USA)

For CGM-arm subjects, glucose data are obtained by the CGM Dexcom G6 which via an iPhone SE 3 transmits data to the in-hospital diabetes team stations to be displayed on an iPad 9 10.2".

DEVICE

FreeStyle Precision Pro Glucometer for glucose POC testing

For the POC-arm subjects, glucose assessment is done by standard ward glucometer.

Sponsors & Collaborators

  • Peter Kristensen

    lead OTHER

Principal Investigators

  • Peter Lommer Kristensen, MD, PhD · Copenhagen University Hospital - North Zealand, Department of Endocrinology and Nephrology, Denmark

  • Katrine Bagge Hansen, MD, PhD · Copenhagen University Hospital - Herlev-Gentofte, Steno Diabetes Center Copenhagen, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-11
Primary Completion
2024-03-29
Completion
2024-07-29
FDA Device
Yes

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05803473 on ClinicalTrials.gov